In Vivo is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ProFibrix BV

Division of The Medicines Co.
www.profibrix.com

Latest From ProFibrix BV

Deals Shaping The Medical Industry, January 2014

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced November through December 2013

BioPharmaceutical Medical Device

Deals Shaping The Medical Industry, September 2013

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing.

BioPharmaceutical Medical Device

Filings In The Second Half Could Be Transformative For The Medicines Co.

The Medicines Co.’s transition away from near-total reliance on Angiomax seems ever closer to reality, given its full pipeline and intensive business development activities. The new products stretch beyond the hospital catheterization lab, as the company builds franchises in hospital anti-infectives, pain management, and hemostatis.

BioPharmaceutical Business Strategies

Medical Device Deals Update, June-July 2013

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, Alliance, and Financing activity.

Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
    • Surgical Equipment & Devices
      • Surgical Sealants
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Dermatology
  • Wound Healing & Tissue Repair
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Benelux
          • Netherlands
  • Parent & Subsidiaries
  • The Medicines Co.
  • Senior Management
  • Jan Ohrstrom, MD, CEO
    Eliane Schutte, Chief Dev. Officer
    Martijn Meijer, VP, Fin.
    Arnoud Dijkstraq, PhD, CBO
  • Contact Info
  • ProFibrix BV
    Phone: (31) 88 86 69 665
    Zernikedreef 9
    Leiden, 2333 CK
    Netherlands
Advertisement
Advertisement
UsernamePublicRestriction

Register